Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell linesBUNDSCHERER, Annika; HAFNER, Christian; MAISCH, Tim et al.Oncology reports. 2008, Vol 19, Num 2, pp 547-553, issn 1021-335X, 7 p.Article

New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-α) treatment of human cancerTAGLIAFERRI, Pierosandro; CARAGLIA, Michele; BUDILLON, Alfredo et al.Cancer immunology and immunotherapy. 2005, Vol 54, Num 1, pp 1-10, issn 0340-7004, 10 p.Article

Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapyBAXEVANIS, Constantin N; PEREZ, Sonia A; PAPAMICHAIL, Michael et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 3, pp 317-324, issn 0340-7004, 8 p.Article

Rewiring the injured CNS : Lessons from the optic nerveBENOWITZ, Larry; YUQIN YIN.Experimental neurology (Print). 2008, Vol 209, Num 2, pp 389-398, issn 0014-4886, 10 p.Article

Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitorsEWALD, Florian; NÖRZ, Dominik; GROTTKE, Astrid et al.Investigational new drugs. 2014, Vol 32, Num 6, pp 1144-1154, issn 0167-6997, 11 p.Article